NCT01709409View on ClinicalTrials.gov

A Multi-center Trial to Determine if Curosurf® Reduces the Duration of Mechanical Ventilation in Very Preterm Infants

PHASE3CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Respiratory Distress Syndrome
Interventions
DRUG

Curosurf-Group1

Maximum of 3 doses are administered to infants diagnosed with RDS.

DRUG

BLES-group 2

Maximum of 3 doses are administered to infants with RDS

Trial Locations (1)

K1H8L6

The Ottawa Hospital, Ottawa

Sponsors
All Listed Sponsors
lead

Ottawa Hospital Research Institute

OTHER

NCT01709409 - A Multi-center Trial to Determine if Curosurf® Reduces the Duration of Mechanical Ventilation in Very Preterm Infants | Biotech Hunter | Biotech Hunter